Author pages are created from data sourced from our academic publisher partnerships and public sources.
- Publications
- Influence
Conventional multiple or microdissection testicular sperm extraction: a comparative study.
- A. Tsujimura, K. Matsumiya, +7 authors A. Okuyama
- Biology, Medicine
- Human reproduction
- 1 November 2002
BACKGROUND
Testicular sperm extraction (TESE) with ICSI is becoming the first-line treatment for non-obstructive azoospermia (NOA). Recently, the sperm retrieval rate (SRR) by microdissection TESE… Expand
Modulation of androgen receptor transactivation by gelsolin: a newly identified androgen receptor coregulator.
- K. Nishimura, Huei-ju Ting, +10 authors C. Chang
- Biology, Medicine
- Cancer research
- 15 August 2003
The partial agonist effect of antiandrogens has been well documented, and such effect is amplified by derived mutant androgen receptors (ARs) in prostate cancer cells. Here we report the… Expand
Increased infiltration of tumor associated macrophages is associated with poor prognosis of bladder carcinoma in situ after intravesical bacillus Calmette-Guerin instillation.
- H. Takayama, K. Nishimura, +5 authors N. Nonomura
- Medicine
- The Journal of urology
- 1 April 2009
PURPOSE
Tumor associated macrophages can regulate the growth of various cancers positively or negatively. Intravesical bacillus Calmette-Guerin instillation is now gold standard treatment for bladder… Expand
KIT (c-kit oncogene product) pathway is constitutively activated in human testicular germ cell tumors.
- Y. Nakai, N. Nonomura, +9 authors A. Okuyama
- Biology, Medicine
- Biochemical and biophysical research…
- 11 November 2005
We investigated the expression of KIT (product of c-kit oncogene), gain-of-function mutations, and activation of its downstream signal transduction in human testicular cancers. KIT was expressed in… Expand
Long-term results of surgical resection for pulmonary metastasis from renal cell carcinoma: a 25-year single-institution experience.
- R. Kanzaki, M. Higashiyama, +5 authors K. Kodama
- Medicine
- European journal of cardio-thoracic surgery…
- 1 February 2011
OBJECTIVE
Despite the report of new treatment options, surgery remains the best treatment for pulmonary metastases from renal cell carcinoma (RCC). Repeat resection is also an effective means for… Expand
Chromosomal variants among 1790 infertile men
- Y. Nakamura, M. Kitamura, +5 authors A. Okuyama
- Medicine
- International journal of urology : official…
- 1 February 2001
Abstract Background: The largest cytogenetic survey involving infertile men was undertaken to clarify whether chromosomal abnormalities, including autosomal abnormalities, affect semen qualities.
Sesquiterpene lactone parthenolide suppresses tumor growth in a xenograft model of renal cell carcinoma by inhibiting the activation of NF‐κB
- D. Oka, K. Nishimura, +7 authors N. Nonomura
- Medicine
- International journal of cancer
- 15 June 2007
The transcription factor nuclear factor‐κB (NF‐κB) has been shown to be constitutively activated in various human malignancies, including leukemia, lymphoma and a number of solid tumors. NF‐κB… Expand
Anticarcinogenic effect of FTY720 in human prostate carcinoma DU145 cells: Modulation of mitogenic signaling, FAK, cell‐cycle entry and apoptosis
- Sompol Permpongkosol, J. Wang, +6 authors A. Okuyama
- Biology, Medicine
- International journal of cancer
- 10 March 2002
Despite the high frequency of prostate cancer, therapeutic options for advanced disease are limited to chemotherapy, radiation or hormonal therapy and eventually fail in all patients. Therefore,… Expand
Surveillance following orchiectomy for stage I testicular seminoma: Long‐term outcome
- T. Yoshida, K. Kakimoto, +6 authors M. Usami
- Medicine
- International journal of urology : official…
- 1 September 2009
Objectives: To report the long‐term outcome of surveillance for stage I seminoma at a single institution in Japan.
One-month relative dose intensity of not less than 50% predicts favourable progression-free survival in sorafenib therapy for advanced renal cell carcinoma in Japanese patients.
- Atsunari Kawashima, H. Takayama, +12 authors N. Nonomura
- Medicine
- European journal of cancer
- 1 July 2011
BACKGROUND
Sorafenib is a multikinase inhibitor used as a second-line treatment for metastatic renal cell carcinoma (mRCC). However, it is very difficult to estimate sorafenib dosage because it is… Expand